ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ImpediMed Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 15.29 | 22.18 | 24.63 | 45.71 | 40.73 |
Cash & Short-Term Investments | 15.29 | 22.18 | 24.63 | 45.71 | 40.73 |
Cash Growth | -31.09% | -9.94% | -46.11% | 12.23% | 106.95% |
Accounts Receivable | 4.68 | 2.42 | 2.19 | 2.63 | 2.75 |
Other Receivables | - | 1.23 | 1.01 | 1.76 | 1.63 |
Receivables | 4.68 | 3.65 | 3.2 | 4.38 | 4.38 |
Inventory | 2.21 | 0.86 | 0.76 | 0.81 | 0.93 |
Prepaid Expenses | 1.35 | 0.81 | 0.86 | 1.03 | 0.62 |
Total Current Assets | 23.53 | 27.51 | 29.46 | 51.94 | 46.66 |
Property, Plant & Equipment | 0.65 | 0.88 | 1.45 | 1.95 | 0.42 |
Long-Term Investments | - | - | - | - | 0.08 |
Goodwill | - | 2.78 | 2.72 | 2.73 | 2.63 |
Other Intangible Assets | 10.17 | 10.19 | 13.31 | 12.04 | 8.74 |
Long-Term Accounts Receivable | 0.27 | 0.23 | - | - | 0.18 |
Other Long-Term Assets | 0.05 | 0.07 | 0.05 | 0.08 | - |
Total Assets | 34.66 | 41.66 | 46.99 | 68.74 | 58.7 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.9 | 1.06 | 1.1 | 1.36 | 2.64 |
Accrued Expenses | 1.24 | 2 | 1.67 | 3.1 | 3.45 |
Current Portion of Leases | 0.3 | 0.27 | 0.33 | 0.3 | 0.17 |
Current Unearned Revenue | 2.63 | 2.33 | 1.49 | 1.03 | 0.93 |
Other Current Liabilities | 0.11 | 0.02 | 0.07 | 0.06 | 0.06 |
Total Current Liabilities | 6.18 | 5.66 | 4.66 | 5.85 | 7.24 |
Long-Term Debt | 16.09 | 13.79 | - | - | - |
Long-Term Leases | 0.21 | 0.43 | 0.81 | 1.15 | - |
Long-Term Unearned Revenue | 1.88 | 1.17 | 0.7 | 0.42 | 0.36 |
Pension & Post-Retirement Benefits | 0.05 | 0.04 | 0.05 | 0.42 | - |
Other Long-Term Liabilities | 0.07 | 0.07 | 0.03 | 0.03 | 0.05 |
Total Liabilities | 24.47 | 21.16 | 6.24 | 7.86 | 7.66 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 349.86 | 336.15 | 336.15 | 336.09 | 307.56 |
Retained Earnings | -379.1 | -354.19 | -330.95 | -311.16 | -290.64 |
Comprehensive Income & Other | 39.42 | 38.54 | 35.55 | 35.95 | 34.13 |
Shareholders' Equity | 10.19 | 20.5 | 40.74 | 60.88 | 51.04 |
Total Liabilities & Equity | 34.66 | 41.66 | 46.99 | 68.74 | 58.7 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 16.6 | 14.49 | 1.14 | 1.45 | 0.17 |
Net Cash (Debt) | -1.31 | 7.69 | 23.49 | 44.26 | 40.56 |
Net Cash Growth | - | -67.25% | -46.93% | 9.13% | 111.17% |
Net Cash Per Share | -0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
Filing Date Shares Outstanding | 2,947 | 2,030 | 2,023 | 2,019 | 1,780 |
Total Common Shares Outstanding | 2,947 | 2,027 | 2,023 | 2,018 | 1,778 |
Working Capital | 17.35 | 21.85 | 24.8 | 46.09 | 39.42 |
Book Value Per Share | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 |
Tangible Book Value | 0.02 | 7.53 | 24.72 | 46.11 | 39.68 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
Machinery | - | 2.87 | 2.84 | 2.79 | 2.72 |
Leasehold Improvements | - | 0.19 | 0.19 | 0.19 | 0.19 |